Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. Read more about Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Targeting activated KIT signaling for melanoma therapy. Read more about Targeting activated KIT signaling for melanoma therapy.
Re-examining racial disparities in prostate cancer outcomes. Read more about Re-examining racial disparities in prostate cancer outcomes.
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Read more about Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Reply to M.-E. Percival et al and L.B. Saltz. Read more about Reply to M.-E. Percival et al and L.B. Saltz.
Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial. Read more about Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. Read more about Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Read more about Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
